- Medical Devices
- 1 min read
Philips clarifies respiratory device replacement numbers after new FDA rebuke
The Dutch healthcare equipment maker issued a statement clarifying progress of the recall program underway since 2021 after the FDA issued a statement on April 13 saying that the number of devices the company had replaced was "considerably less" than the 2.46 million indicated on the company's website.
Read by
The Dutch healthcare equipment maker issued a statement clarifying progress of the recall program underway since 2021 after the FDA issued a statement on April 13 saying that the number of devices the company had replaced was "considerably less" than the 2.46 million indicated on the company's website.
Philips shares were down 2.7 per cent at 16.32 euros at 0842 GMT in Amsterdam.
Join the community of 2M+ industry professionals
Subscribe to our newsletter to get latest insights & analysis.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions